Monographie - Ursodesoxycholique acid

Ursodesoxycholique acid

Stabilitása gyógyszerészeti készítmények

Kémiai szerkezet

Irodalom : Ursodesoxycholique acid

	Type	Publikáció
2410	Napló	Johnson CE, Streetman DD. Stability of oral suspensions of ursodiol made from tablets Am J Health-Syst Pharm 2002 ; 59: 361-363.
2449	Napló	Johnson CE, Nesbitt J. Stability of ursodiol in an extemporaneously compounded oral liquid Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
3782	Napló	A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration Int J Pharm 2014 , 477, 1-2 : 32-38.
4177	Napló	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526
4214	Napló	Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Int J Pharm Compound 2019 ;23,1:70-76
4498	Napló	Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T. Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns. Pharmaceutical Technology in Hospital Pharmacy 2020